Novartis launches legal challenge against PCT cluster


Source: llandrea

A pharmaceutical company is taking a primary care trust cluster to court over its decision to encourage the use of a cheaper, unlicensed drug in a case that could be worth millions to the NHS.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here